Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by J. Safra Sarasin Holding AG

Key Points

• J. Safra Sarasin Holding AG increased its stake in Intuitive Surgical, Inc. by 55.8%, now holding 16,216 shares, valued at approximately $8.03 million.
• Intuitive Surgical reported $2.19 earnings per share for the last quarter, exceeding analysts' expectations of $1.93 and achieving a year-over-year revenue growth of 21.4%.
• Several hedge funds have also adjusted their holdings in Intuitive Surgical, with institutional investors owning 83.64% of the company's stock, indicating strong interest and confidence in the company.

J. Safra Sarasin Holding AG grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 55.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,216 shares of the medical equipment provider's stock after acquiring an additional 5,807 shares during the quarter. J. Safra Sarasin Holding AG's holdings in Intuitive Surgical were worth $8,031,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. Brighton Jones LLC increased its stake in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after acquiring an additional 731 shares during the last quarter. Bank Pictet & Cie Europe AG increased its position in shares of Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after purchasing an additional 883 shares during the last quarter. World Investment Advisors increased its position in shares of Intuitive Surgical by 97.4% during the 4th quarter. World Investment Advisors now owns 916 shares of the medical equipment provider's stock worth $478,000 after purchasing an additional 452 shares during the last quarter. Arete Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 78.3% during the 4th quarter. Arete Wealth Advisors LLC now owns 1,908 shares of the medical equipment provider's stock worth $996,000 after purchasing an additional 838 shares during the last quarter. Finally, Prudential PLC increased its position in shares of Intuitive Surgical by 18.3% during the 4th quarter. Prudential PLC now owns 23,801 shares of the medical equipment provider's stock worth $12,423,000 after purchasing an additional 3,679 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. UBS Group raised their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. BTIG Research raised their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Finally, Royal Bank Of Canada raised their price objective on Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 23rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $595.95.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of the business's stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the sale, the insider owned 18,520 shares of the company's stock, valued at approximately $9,171,844.80. The trade was a 13.13% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,903 shares of company stock worth $7,932,778 over the last 90 days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $2.90 during midday trading on Tuesday, hitting $480.46. The company had a trading volume of 551,963 shares, compared to its average volume of 1,997,479. The company's 50-day simple moving average is $522.89 and its 200-day simple moving average is $531.90. The firm has a market capitalization of $172.23 billion, a P/E ratio of 67.17, a P/E/G ratio of 5.06 and a beta of 1.59. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.78 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.